Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Silence Therapeutics Receives $2M Milestone Payment from Hansoh | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Silence Therapeutics Receives $2M Milestone Payment from Hansoh

Achieves a second undisclosed milestone related to the first target under the collaboration.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Silence Therapeutics plc, a biotechnology company committed to transforming peoples’ lives by “silencing” diseases through precision engineered medicines, will receive a $2.0 million cash payment from Hansoh Pharmaceutical Group Company Limited following the achievement of a second undisclosed milestone related to the first target under the collaboration.
 
“This represents an important milestone in our efforts to advance this program into the clinic with Hansoh,” said Craig Tooman, President and CEO of Silence. “This is an exciting time for Silence and our mRNAi GOLD platform as we continue to advance and expand our pipeline targeting a wide range of genetic diseases.”
 
Silence and Hansoh entered a collaboration in October 2021 to develop siRNAs (short interfering RNAs) leveraging Silence’s proprietary mRNAi GOLD platform for three undisclosed targets. Under the terms of the agreement, Silence has exclusive rights to the first two targets in all territories except the China region. Hansoh has the exclusive option to license rights to those two targets in the Greater China, Hong Kong, Macau and Taiwan, and global rights to the third target.
 
Today’s announcement represents the fourth research milestone payment achieved under the collaboration.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics